« Back
Home /
Polyclonal Antibody to Protein Tyrosine Phosphatase Receptor Type C (CD45)

Polyclonal Antibody to Protein Tyrosine Phosphatase Receptor Type C (CD45)

Manufacturer	Cloud-Clone
Category	Oncology Neuroscience Neural Lineage Markers Metabolism Diabetes Antibodies By Cell Type Blastoma Carcinoma Glioma Hematology Leukemia Lymphoma Myeloma Melanoma Sarcoma Cell Biology Cell Status Adenocarcinoma Immunohistochemistry Immunoprecipitation Western Blot Immunocytochemistry Oxidative Stress Primary Antibodies Progenitor Markers
Type	Antibody Polyclonal
Specific against	Human
Applications	WB, IP, IHC, ICC
Amount	20ul
Host	Rabbit
Item no.	PAB030Hu01-20ul
Targets	PTPRC, PTEN, PRCC, CPD
eClass 6.1	32160702
eClass 9.0	32160702
Available
Alias	PTPRC, PTPR-C, LCA, B220, GP180, LY5, T200, Leukocyte common antigen
Quantity options
Alternative Names	PTPRC, PTPR-C, LCA, B220, GP180, LY5, T200, Leukocyte common antigen
Research Area	Signal transduction, Tumor immunity, Infection immunity,
Buffer Formulation	0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Immunogen	RPB030Hu01-Recombinant Protein Tyrosine Phosphatase Receptor Type C (CD45)
Usage	Western blotting: 0.5-2ug/mL; Immunohistochemistry: 5-20ug/mL; Immunocytochemistry: 5-20ug/mL; Optimal working dilutions must be determined by end user.
Traits	Liquid
Purification	Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.